Abstract:
The present invention provides a novel compound having an antiviral action, in particular, an HIV replication inhibiting action, as well as a pharmaceutical composition, in particular, an anti-HIV agent. wherein, a broken line means the presence or absence of a bond; R 1 is substituted or unsubstituted alkyl etc., R 2 is substituted or unsubstituted alkyloxy etc.; n is 1 or 2; R 3 is a substituted or unsubstituted aromatic carbocyclic group; R 4 is a hydrogen atom etc.; R 5 is a substituted or unsubstituted aromatic carbocyclic group etc.; Y is a single bond etc.; R 6 is substituted or unsubstituted alkyl; R 7 is -Z-R 71 etc.; Z is - NR 72 -CO- etc.; R 71 is substituted or unsubstituted alkyl etc.; R 72 is a hydrogen atom etc.
Abstract:
The present invention provides a novel compound having an antiviral action, in particular, an HIV replication inhibiting action, as well as a pharmaceutical composition, in particular, an anti-HIV agent.
wherein, a broken line means the presence or absence of a bond; R 1 is substituted or unsubstituted alkyl etc., R 2 is substituted or unsubstituted alkyloxy etc.; n is 1 or 2; R 3 is a substituted or unsubstituted aromatic carbocyclic group; R 4 is a hydrogen atom etc.; R 5 is a substituted or unsubstituted aromatic carbocyclic group etc.; Y is a single bond etc.; R 6 is substituted or unsubstituted alkyl; R 7 is -Z-R 71 etc.; Z is - NR 72 -CO- etc.; R 71 is substituted or unsubstituted alkyl etc.; R 72 is a hydrogen atom etc.
Abstract:
A reactor apparatus includes at least one reaction capillary having a lumen for receiving a reactant to undergo a reaction, and a magnetron for irradiating reactant contained in at least a portion of the capillary with microwaves. A method of micro-reacting a reactant includes providing a capillary, and irradiating the reactant in the capillary with microwaves to facilitate a chemical reaction in the capillary by which the reactant is converted into a desired product.
Abstract:
Compounds represented by general formula (I) or salts thereof, wherein n is an integer of 2 or 3; R represents a straight-chain or branched saturated alkyl group having 4 or 5 carbon atoms, a cyclopentyl group, a cyclohexyl group or the like; Y represents a hydroxyl or amino group; A represents a hydrogen atom, a hydroxyl, methoxy, nitro group or the like; Q represents a hydrogen atom or a hydroxyl or methoxy group. They can be formulated to give pharmaceutical compositions that are effective as prophylactic or therapeutic agents for allergic diseases associated with IgE production inhibitors or IgE antibodies.
Abstract:
Production of chlorine-substituted olefine compounds of formula (I), wherein: R1 represents a C-organic rest; R2 represents -CN, -CO-R3, -CO-S-R3, -CO-O-R3, -CO-N(R?4, R5); R3¿ represents a C-organic rest; R4, R5 represent H, C-organic rest. The process is bared on the reaction of oxiranes of formula (II) in the presence of a carboxylic acid amide (IIIa) or a lactam (IIIb) in the liquid phase with a chlorinating agent of formula (IV). Process products of formula (I) are important intermediate products for the production of dyes, pharmaceuticals and plant-protecting agents.